Related references
Note: Only part of the references are listed.Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation
Deepak Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity
Filomena Martins et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Antibacterial activity of adamantyl substituted cyclohexane diamine derivatives against methicillin resistant Staphylococcus aureus and Mycobacterium tuberculosis
Beena et al.
RSC ADVANCES (2014)
Synthesis and bioevaluation of some new isoniazid derivatives
Lilia Matei et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives
Deepak Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Antibiotics in the clinical pipeline in 2013
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2013)
Antituberculosis Drug Research: A Critical Overview
Beena et al.
MEDICINAL RESEARCH REVIEWS (2013)
Novel isoniazid cyclocondensed 1,2,3,4-tetrahydropyrimidine derivatives for treating infectious disease: a synthesis and in vitro biological evaluation
Karthikeyan Elumalai et al.
JOURNAL OF ACUTE DISEASE (2013)
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthesis and Evaluation of 5-Benzylidenethiazolidine-2,4-dione Derivatives for the Treatment of Non-Alcoholic Fatty Liver Disease
Liang Ma et al.
ARCHIV DER PHARMAZIE (2012)
Synthesis and Antitubercular Activity Evaluation of Novel Unsymmetrical Cyclohexane-1,2-diamine Derivatives
Beena et al.
ARCHIV DER PHARMAZIE (2012)
Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation
Addepalli Venkata Ramani et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Synthesis, molecular docking study and antitumor activity of novel 2-phenylindole derivatives
Sally S. El-Nakkady et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Tuberculosis: The drug development pipeline at a glance
Baptiste Villemagne et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
India reports cases of totally drug-resistant tuberculosis
Samuel Loewenberg
LANCET (2012)
Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues
Thimmappa H. Manjashetty et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
New tuberculosis drugs on the horizon
Stewart T. Cole et al.
CURRENT OPINION IN MICROBIOLOGY (2011)
New series of isoniazid hydrazones linked with electron-withdrawing substituents
Eva Vavrikova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
New fluorine-containing hydrazones active against MDR-tuberculosis
Eva Vavrikova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease
Liang Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
Prithwiraj De et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strain
Nubia Boechat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
HIV-Associated Tuberculosis: Clinical Update
Soumya Swaminathan et al.
CLINICAL INFECTIOUS DISEASES (2010)
Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N′-(2-chloroethyl)ureas
Sebastien Fortin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Tuberculosis drug development: Progress, challenges, and the road ahead
Ann M. Ginsberg
TUBERCULOSIS (2010)
Amide derivatives of ethacrynic acid: Synthesis and evaluation as antagonists of Wnt/β-catenin signaling and CLL cell survival
Guangyi Jin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran
Ali Akbar Velayati et al.
CHEST (2009)
Multidrug-resistant and extensively drug-resistant tuberculosis: The National Institute of Allergy and Infectious Diseases research agenda and recommendations for priority research
Anthony S. Fauci
JOURNAL OF INFECTIOUS DISEASES (2008)
Recent Developments in Antitubercular Drugs
Pallavi Ahirrao
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5′-N-ethylearboxamido-adenosines:: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor
Pier Giovanni Baraldi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant
XB Zhao et al.
BIOCHEMISTRY (2006)
Tuberculosis and HIV co-infection - A practical therapeutic approach
Ronan A. M. Breen et al.
DRUGS (2006)
Advances in the discovery of novel antibacterial agents during the year 2002
CR Harris et al.
CURRENT MEDICINAL CHEMISTRY (2004)
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase:: Adduct affinity and drug resistance
R Rawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
In vitro antimycobacterial activities of 2′-monosubstituted isonicotinohydrazides and their cyanoborane adducts
R Maccari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
